SOL-GEL TECHNOLOGIES LTD (SLGL)
IL0011417206 - Common Stock
SOL-GEL TECHNOLOGIES LTD
NASDAQ:SLGL (5/17/2024, 7:26:37 PM)
0.75
+0.01 (+1.46%)
Company Profile
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Company Info
SOL-GEL TECHNOLOGIES LTD
Golda Meir 7
Ness Ziona 7403648
P: 97289313433
CEO: Alon Seri-Levy
Employees: 55
Website: http://www.sol-gel.com
SLGL News
Sol-Gel and Beimei Pharma annouce an Asset Purcase Agreement to commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel...
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream...
Sol-Gel Reports Full Year 2023 Financial Results and Corporate Developments...
SGT-610 has “Orphan Drug” designation status in the U.S. and E.U. and “Breakthrough Therapy” designation status in the U.S., as potentially the first and...
Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease...
Sol-Gel on track to advance Orphan Drug candidate, SGT-610 (patidegib) for Gorlin syndrome into Phase 3 testing in late 2023Gorlin Syndrome KOL event to be...
SLGL Twits
Here you can normally see the latest stock twits on SLGL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
